pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,256 catalysts · 5,256 phase readout · 2,309 8k filing · 317 pdufa · 259 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 38 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: drug expiry×type: phase readout×clear all
type
  • phase readout5,256
  • 8k filing2,309
  • pdufa317
  • earnings259
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›RECRUITINGphase readoutNCT07542431: Impact of Dog Adoption and Training in Veterans With Post-traumatic Stress Symptoms and/or Other Mental Health Conditions

Sponsor: Florida Atlantic University. Phase: NA. Conditions: Posttraumatic Stress Symptoms, Mental Health Conditions

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05763602: PVI to Prevent S. Aureus SSI After Fixation of HELEF (POTENT Study)

Sponsor: Loreen Herwaldt. Phase: PHASE4. Conditions: Surgical Site Infection

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07550439: Effect of World Health Organization Labour Care Guide On Reducing Cesarean Section Rates

Sponsor: Pak Emirates Military Hospital. Phase: NA. Conditions: Labour

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07602465: The Impact of Blood Pressure Variability During the Induction and Surgical Periods on Postoperative Acute Kidney Injury

Sponsor: Zhongda Hospital. Phase: . Conditions: Acute Kidney Injury (AKI)

full page →ctgov ↗
›RECRUITINGphase readoutNCT03773965: A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis

Sponsor: Eli Lilly and Company. Phase: PHASE3. Conditions: Juvenile Idiopathic Arthritis

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07413965: TAVR vs SAVR in Severe Bicuspid Aortic Stenosis

Sponsor: Cedars-Sinai Medical Center. Phase: NA. Conditions: Bicuspid Aortic Valve Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT06923267: Ultrasound Evaluation of Cardiac Function During Spontaneous Breathing Trials

Sponsor: Centre Hospitalier Régional d'Orléans. Phase: NA. Conditions: Weaning Invasive Mechanical Ventilation, Weaning-induced Pulmonary Edema, Weaning Failure of Mechanical Ventilation, Spontaneous Breathing Test, Intensive Care Units (ICUs)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07545967: Re-radiotherapy Combined With Chidamide for the Treatment of Recurrent Head and Neck Squamous Cell Carcinoma After Radiotherapy

Sponsor: West China Hospital. Phase: PHASE1. Conditions: Head and Neck Squamous Cell Carcinoma HNSCC

full page →ctgov ↗
›RECRUITINGphase readoutNCT07196007: Leveraging Community-clinical Linkages to Address Unmet Social Needs for People With Diabetes

Sponsor: Mary Lacy. Phase: NA. Conditions: Diabetes, Diabetes Mellitus

full page →ctgov ↗
›COMPLETEDphase readoutNCT00862992: Safety, Pharmacokinetics and Efficacy Study of MP-214 in Patients With Schizophrenia

Sponsor: Tanabe Pharma Corporation. Phase: PHASE2. Conditions: Schizophrenia

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07612592: The Clinical Application Study of Obinutuzumab in Pediatric Refractory Nephrotic Syndrome

Sponsor: Children's Hospital of Chongqing Medical University. Phase: . Conditions: Primary Nephrotic Syndrome

full page →ctgov ↗
›RECRUITINGphase readoutNCT04972136: rTMS for Depression in Young Adults With Autism

Sponsor: Centre for Addiction and Mental Health. Phase: NA. Conditions: Autism Spectrum Disorder, Major Depressive Disorder

full page →ctgov ↗
›COMPLETEDphase readoutNCT01805336: Assessment of Attentional and Executive Disorders in Multiple Sclerosis Using Techniques of Virtual Reality

Sponsor: University Hospital, Caen. Phase: NA. Conditions: Relapsing-Remitting Multiple Sclerosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT07097311: Study to Evaluate the Use of Triheptanoin in Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)

Sponsor: Jerry Vockley, MD, PhD. Phase: PHASE2. Conditions: Medium-chain Acyl-CoA Dehydrogenase Deficiency

full page →ctgov ↗
›TERMINATEDphase readoutNCT04519671: Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn's Disease

Sponsor: Anthony Lembo. Phase: PHASE1. Conditions: Perianal Crohn Disease, Perianal Fistula, Crohn Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT07436364: Application of Contrast-enhanced Ultrasound in Monitoring Soft Tissue Sarcoma Response to Neoadjuvant Radiotherapy

Sponsor: Thomas Jefferson University. Phase: EARLY_PHASE1. Conditions: Soft Tissue Sarcoma

full page →ctgov ↗
›TERMINATEDphase readoutNCT04548609: Transcranial Direct Current Stimulation (tDCS) in Pediatric Obsessive Compulsive Disorder (OCD)

Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Obsessive-Compulsive Disorder, Pediatric Psychiatric Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT04328298: French Register Of Patients With Hemopathy Eligible For CAR-T Cell Treatment (DESCAR-T)

Sponsor: The Lymphoma Academic Research Organisation. Phase: . Conditions: Hematopathology Eligible or CAR-t Cell Treatment

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05565599: An Early Feasibility Study Evaluating the Safety and Efficacy of the Laminar Left Atrial Appendage Closure System in Subjects With Non-Valvular Atrial Fibrillation

Sponsor: Biosense Webster, Inc.. Phase: NA. Conditions: Non-valvular Atrial Fibrillation

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07404098: Efficacy Of Eggshell-Derived Nanohydroxyapatite Based Mineralized Plasmatic Matrix Versus Xenogeneic Based Mineralized Plasmatic Matrix in Posterior Mandibular Socket Preservation

Sponsor: Cairo University. Phase: NA. Conditions: Alveolar Bone Resorption, Socket Preservation, Wound Healing, Nano-hydroxyapatite

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07216963: The Community Paramedic Response and Overdose Outreach With Supportive Medical-Legal Services Study

Sponsor: Duke University. Phase: NA. Conditions: Opioid Use Disorder, Overdose, Drug, Overdose, Substance Use (Drugs, Alcohol)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07288463: Hearing Loss and Brain Health Study

Sponsor: University of Southern California. Phase: NA. Conditions: Hearing Loss, Adult-Onset, Dementia

full page →ctgov ↗
›RECRUITINGphase readoutNCT07139314: Timing of Anticoagulation After Emergency Endovascular Therapy for Acute Ischemic Stroke With Atrial Fibrillation 2

Sponsor: Capital Medical University. Phase: NA. Conditions: Ischemic Stroke, Atrial Fibrillation

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06993116: A Phase I Study of SHR-4712 in Patients With Advanced Solid Tumors

Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd. Phase: PHASE1. Conditions: Advanced Solid Tumor

full page →ctgov ↗
›RECRUITINGphase readoutNCT03126916: Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

Sponsor: Children's Oncology Group. Phase: PHASE3. Conditions: Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular, Neuroblastoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT04744116: Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host Disease

Sponsor: M.D. Anderson Cancer Center. Phase: EARLY_PHASE1. Conditions: Hematopoietic and Lymphoid Cell Neoplasm, Steroid Refractory Graft Versus Host Disease

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07410052: Microbiome-Targeted Enhancement of Neurocognition With Probiotics-Riboflavin Combination

Sponsor: Center for Health Sciences, Serbia. Phase: NA. Conditions: Cognitive Deficits, Mild

full page →ctgov ↗
›COMPLETEDphase readoutNCT07365852: Accuracy Assessment of Chin Graft for Ridge Augmentation Using Tooth-supported Guide Versus Free Hand Technique

Sponsor: Cairo University. Phase: NA. Conditions: Alveolar Bone Loss

full page →ctgov ↗
›COMPLETEDphase readoutNCT03321552: PROMISE International

Sponsor: LimFlow SA. Phase: NA. Conditions: Critical Limb Ischemia

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT05741242: A Phase 1b/2, Multi-center, Single Arm Study to Assess the Safety and Efficacy of Neoantigen Synthetic Long Peptide Vaccines in Patients With Local Or Metastatic Solid Tumors

Sponsor: Jaime Leandro Foundation for Therapeutic Cancer Vaccines. Phase: PHASE1. Conditions: Cancer, Solid Tumor

full page →ctgov ↗
›RECRUITINGphase readoutNCT06940986: The PROmoting Pain Self-Management (PROs) Trial: Holistic Pain Care in the Military Health System

Sponsor: Brooke Army Medical Center. Phase: NA. Conditions: Chronic Pain, Musculoskeletal Pain, Musculoskeletal Pain Disorder

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07538973: A Clinical Study to Evaluate the Pharmacokinetics and Safety of Anecatibin Fumarate Capsules in Subjects With Impaired Liver Function Versus Normal Liver Function

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Phase: PHASE1. Conditions: Lung Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07563673: Early Low-dose ASpirin Use After Intravenous Thrombolysis for Acute Ischemic Cerebral Infarction(ELASTIC)

Sponsor: Beijing Chao Yang Hospital. Phase: PHASE4. Conditions: Cerebral Infarction, Thrombolysis

full page →ctgov ↗
›RECRUITINGphase readoutNCT07602283: Music for Pain and Dementia

Sponsor: Yale University. Phase: NA. Conditions: Alzheimer Disease, Dementia, Mild Cognitive Impairment, Peer-bonded Caregiver, Caregiver

full page →ctgov ↗
›WITHDRAWNphase readoutNCT04707183: Comparison of Continuous Intravenous Lidocaine Infusion Versus ESP Block for Rib Fracture Analgesia

Sponsor: Stanford University. Phase: PHASE2. Conditions: Rib Fractures

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04455841: INCB000928 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Anemia Due to Myeloproliferative Disorders

Sponsor: Incyte Corporation. Phase: PHASE1. Conditions: Anemia, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03198494: Acoustic Stimulation for Seizure Suppression

Sponsor: NYU Langone Health. Phase: NA. Conditions: Epilepsy

full page →ctgov ↗
›COMPLETEDphase readoutNCT05925166: Recombinant Human Tumor Necrosis Factor-α Receptor Ⅱ Fusion Protein in the Treatment of Acute Gout

Sponsor: Lihua Duan. Phase: NA. Conditions: Acute Gout

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07592156: Immersive Virtual Reality Versus Conventional Physiotherapy for Shoulder Tendinopathy

Sponsor: Universidad de Burgos. Phase: NA. Conditions: Shoulder Tendinopathy

full page →ctgov ↗
›RECRUITINGphase readoutNCT06310551: First Time in Human Study of Long Acting VH4524184 Formulations

Sponsor: ViiV Healthcare. Phase: PHASE1. Conditions: HIV Infections

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03624751: Follow up for Patients With Thyroid Cancer Planed for Radioiodine Scan or Treatment

Sponsor: Taichung Veterans General Hospital. Phase: . Conditions: Thyroid Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT05962151: Refractory Chronic Cough Improvement Via NAL ER (RIVER)

Sponsor: Trevi Therapeutics. Phase: PHASE2. Conditions: Refractory Chronic Cough

full page →ctgov ↗
›TERMINATEDphase readoutNCT05209737: Trendelenburg as a First-line Intervention in Critically Ill, Sedated, Invasively Mechanically Ventilated, Hypotensive Patients

Sponsor: Negovsky Reanimatology Research Institute. Phase: NA. Conditions: Hypotension, Shock

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06642337: Nutritional Educational Program On Therapy in Iron Deficiency Anemia

Sponsor: Hawler Medical University. Phase: NA. Conditions: Iron Deficiency Anemia (IDA), Nutrition Disorders, Growth Retardation

full page →ctgov ↗
›COMPLETEDphase readoutNCT06556745: Pharmacokinetics of Butyrate Tablet BKR-017

Sponsor: BioKier Inc.. Phase: . Conditions: Hypercholesterolemia

full page →ctgov ↗
›COMPLETEDphase readoutNCT06739772: Development of Implementation Toolkits

Sponsor: Baylor University. Phase: NA. Conditions: Self Sampling, Communication Model, Implementation Science, HIV

full page →ctgov ↗
›COMPLETEDphase readoutNCT05066672: Phase 2 Study of NV-5138 in Adults With Treatment Resistant Depression

Sponsor: Navitor Pharmaceuticals, Inc.. Phase: PHASE2. Conditions: Treatment Resistant Depression

full page →ctgov ↗
›COMPLETEDphase readoutNCT07018895: Personalized Hypoxic-hyperoxic Preconditioning in Elderly People

Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences. Phase: NA. Conditions: Preconditioning

full page →ctgov ↗
›WITHDRAWNphase readoutNCT06493539: CiNPWT Lower Extremity Amputations (Closed Incision Neagtive Pressure Wound Therapy)

Sponsor: University of Southern California. Phase: PHASE1. Conditions: Wound Heal, Wound Dehiscence

full page →ctgov ↗
›COMPLETEDphase readoutNCT06513377: Evaluating and Monitoring Physical Fatigue While Performing Functional Activities

Sponsor: Vrije Universiteit Brussel. Phase: NA. Conditions: Stroke, Sarcopenia, Fatigue

full page →ctgov ↗
← prev
page 40 of 106
next →